 Obesity
"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 4 | 6 | | 1997 | 4 | 4 | 8 | | 1998 | 5 | 3 | 8 | | 1999 | 9 | 4 | 13 | | 2000 | 5 | 5 | 10 | | 2001 | 11 | 1 | 12 | | 2002 | 18 | 5 | 23 | | 2003 | 19 | 7 | 26 | | 2004 | 36 | 15 | 51 | | 2005 | 39 | 13 | 52 | | 2006 | 31 | 13 | 44 | | 2007 | 34 | 16 | 50 | | 2008 | 53 | 17 | 70 | | 2009 | 60 | 28 | 88 | | 2010 | 62 | 17 | 79 | | 2011 | 76 | 18 | 94 | | 2012 | 63 | 20 | 83 | | 2013 | 77 | 30 | 107 | | 2014 | 58 | 31 | 89 | | 2015 | 91 | 36 | 127 | | 2016 | 68 | 31 | 99 | | 2017 | 68 | 30 | 98 | | 2018 | 74 | 30 | 104 | | 2019 | 80 | 38 | 118 | | 2020 | 33 | 41 | 74 | | 2021 | 34 | 49 | 83 | | 2022 | 26 | 78 | 104 | | 2023 | 24 | 71 | 95 | | 2024 | 42 | 48 | 90 | | 2025 | 61 | 13 | 74 | | 2026 | 39 | 10 | 49 |
To return to the timeline, click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Tabasso C, Gavini CK, Zemski Berry K, Salem H, Aguettaz AKF, Lagarrigue S, Bergman BC, Mansuy-Aubert V, Amati F. Organelle-Specific Lipid Profiles Underlie Metabolic Health in a Nutrition-Dependent Manner. Diabetes. 2026 Oct 01; 75(10):1753-1766.
-
Velazquez S, Juber MC, Okun M, Lau E, Ashkarran AA. Body mass index-specific nanoparticle protein corona signatures in late pregnancy. Nanoscale. 2026 Sep 10; 18(34):18571-18583.
-
Valdez Y, Segev N, Parimi N, Vegesna M, Brown EA, Samuels S, Van Name M, Shah AS, Wolf RM. Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis. J Pediatr Endocrinol Metab. 2026 Oct 26; 39(10):1007-1016.
-
Colangelo H, Nestler A, Lyon C. Not Just for Diabetes: The Next Frontier for GLP-1 Agonists. J Am Board Fam Med. 2026 Aug; 39(1).
-
Koethe JR, Lake JE, Kantor A, Smeaton L, Erlandson K, Moran L, Belaunzaran-Zamudio P, Landay A, Campo RE, Debroy P, Bennet JA, O'Halloran J, Han WM, Alli O, Leonard M, Gulick RM. A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). Clin Infect Dis. 2026 Jul 23; 83(1):e81-e89.
-
Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA. Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial. JMIR Res Protoc. 2026 Jul 23; 15:e86281.
-
Athinarayanan SJ, Bjornstad P, Shanmugam PV, Weimbs T, Wolfberg AJ, Volek JS, Himmelfarb J, Johnson RJ. Effectiveness of Telehealth Low-Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real-World, Retrospective, Matched Cohort Study. Diabetes Obes Metab. 2026 10; 28(10):9054-9068.
-
Yeo EN, Scadden AW, Caterer ZT, Sutton KJ, Konigsberg IR, Cole JB, Litkowski EM, Pan Z, Lozupone CA, Ostendorf DM, MacLean PS, Melanson EL, Bessesen DH, Borengasser SJ, Lange EM, Catenacci VA, Stanislawski MA. Multi-omic modelling of body mass index response to a dietary weight loss intervention. Gut Microbes. 2026 Dec 31; 18(1):2696645.
-
Miller JL, van Santen HM, Phillips SA, Hamilton J, Aberle J, Sathyapalan T, Mohamed Z, McCormack SE, Shoemaker AH, Kelsey MM, Ghalib L, Stalla G, Thaker VV, Habiby R, Ode KL, Wabitsch M, Dattani M, Abuzzahab MJ, Abdullatif H, Morgan R, Stefater-Richards M, Aroda VR, Friedrich C, Han JC, Ono H, Nagasaki K, Tanaka T, Isojima T, Arima H, Scimia C, Yuan G, Müller HL, Roth CL. Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. N Engl J Med. 2026 Jul 09; 395(2):138-150.
-
Zuraikat FM, Scaccia SE, Cochran JA, Cheng B, Diaz KM, Creasy SA, Melanson EL, Shen W, Aggarwal B, Jelic S, St-Onge MP. Prolonged Short Sleep and Its Effect on Body Weight and Composition : A Pooled Analysis of Randomized Trials. Ann Intern Med. 2026 Aug; 179(8):1085-1093.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|